Cost Effectiveness of Specific Treatments

Wednesday, June 13, 2018: 8:00 AM-9:30 AM
Oak Amphitheater - Garden Level (Emory Conference Center Hotel)
Organizer:
Andres Berruti
8:00 AM
Intravitreal Aflibercept Compared to Ranibizumab for Wet Age‐related Macular Degeneration in the US: Cost-effectiveness Analysis

Author(s): Andreas Kuznik; Luis Hernandez; Tereza Lanitis; Hector Toro-Diaz; Clifford Cele; Andrea Gibson

Discussant: James Henson
8:20 AM
Comparing Cost Effectiveness of Aripiprazole Augmentation with Other “Next-Step” Depression Treatment Strategies

Author(s): Jean Yoon

Discussant: Yasin Civelek
8:40 AM
Estimating the Cost of Rapid Home HIV testing within a Randomized Controlled Trial in the United States

Author(s): Ram K. Shrestha; Pollyanna Chavez; Meredith Noble; Stephanie Sansom; Patrick Sullivan; Robin MacGowan

Discussant: Andres Berruti
See more of: Costs and Benefits of Specific Medical Treatments
<< Previous Session | Next Session >>

American Society of Health Economists (ASHEcon)

1100 Vermont Avenue NW Suite 650

Washington, DC 20005

P: (202) 737 6608

F: (202) 496 0134

Copyright © 2017 ASHEcon - All rights reserved.